Home
>
US Stocks
>
Kinnate Biopharma Inc
Kinnate Biopharma Inc
KNTE

Kinnate Biopharma Inc

$22.17.18%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
21.6
Today Low/High
21.41 / 22.1
52 Week Low/High
$17.6 / $48.75
Market Cap
$781.34M

Company Details

Kinnate is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically defined cancers. Kinnate’s mission is to expand the reach of targeted therapeutics by developing products for underserved populations. Kinnate utilizes its deep expertise in structure-based drug discovery, translational research, and patient-driven precision medicine, which it refers to as the Kinnate Discovery Engine, to develop targeted therapies. Based in San Francisco and San Diego, California, the Kinnate team is composed of drug discovery experts supported by a distinguished group of scientific advisors.
Organisation
Kinnate Biopharma Inc
Employees
31

Discover more

Frequently Asked Questions

What is Kinnate Biopharma Inc share price today

Can Indians buy Kinnate Biopharma Inc shares?

How can I buy Kinnate Biopharma Inc shares from India?

Can Fractional shares of Kinnate Biopharma Inc be purchased?

What are the documents required to start investing in Kinnate Biopharma Inc stocks?

We are a SEBI registered investement advisor